Outcomes in patients receiving fixed-dosed aflibercept for treatment-na ïve neovascular age-related macular degeneration during one year of routine clinical practice.

CONCLUSION: Aflibercept administered by fixed dosing over one year improved visual acuity and macular morphology in treatment-naïve eyes in routine daily practice. PMID: 31182243 [PubMed - as supplied by publisher]
Source: Archivos de la Sociedad Espanola de Oftalmologia - Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research